FindTrial
Sign In

A real-world study of high intraocular pressure in thyroid-related ophthalmopathy.

A real-world study of high intraocular pressure in thyroid-related ophthalmopathy.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000038190
Enrollment
Unknown
Registered
2020-09-13
Start date
2020-12-01
Completion date
Unknown
Last updated
2020-11-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid-related ophthalmopathy

Interventions

low IOP group:Nil
mid IOP group:Nil
high IOP group:Nil

Sponsors

Peking University Third Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: At the same time meet the following two: 1. According to EUGOGO diagnostic criteria, patients with thyroid-related ophthalmopathy (TAO) were diagnosed. 2. The intraocular pressure (IOP) measured by a Goldmann and/or a rebounding tonometer (iCare) discontinuously for three times exceeds 21mmHg;

Exclusion criteria

Exclusion criteria: Aged > 80 years.

Design outcomes

Primary

MeasureTime frame
intraocular pressure;visual field;RNFL;drugs;surgery;—

Countries

China

Contacts

Public ContactChun Zhang

Peking University Third Hospital

zhangc1@yahoo.com+86 18601031059

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026